Llwytho...
Use of broadly neutralizing antibodies for HIV-1 prevention
Antibodies have a long history in antiviral therapy, but until recently they have not been actively pursued for HIV-1 due to modest potency and breadth of early human monoclonal antibodies (MAbs) and perceived insurmountable technical, financial, and logistical hurdles. Recent advances in the identi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Immunol Rev |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5314445/ https://ncbi.nlm.nih.gov/pubmed/28133803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12511 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|